Organon ANZ is a new global, leading Women’s Healthcare/biopharmaceutical company - a spinoff of MSD Global / Merck - with a US$6 Bill PA turnover.Board engagements:• Statutory Board Member - one of three - with responsibility for signoff of financial reporting ($200M) and board oversight;• County Compliance Committee member, Risk mitigation, Remuneration bonus scheme & oversight of sales incentive scheme, COVID Task force member;• Member of Country Leadership Team, Country… Show more Organon ANZ is a new global, leading Women’s Healthcare/biopharmaceutical company - a spinoff of MSD Global / Merck - with a US$6 Bill PA turnover.Board engagements:• Statutory Board Member - one of three - with responsibility for signoff of financial reporting ($200M) and board oversight;• County Compliance Committee member, Risk mitigation, Remuneration bonus scheme & oversight of sales incentive scheme, COVID Task force member;• Member of Country Leadership Team, Country Strategic planning & implementation.Executive engagement:• Moved from MSD to Organon as the Commercial lead for ANZ Primary Care Division (contraception & dermatology business focus);• One of 11 ANZ Organon Directors, responsible for leading the Primary Care commercial division and reporting to a local Managing Director;• Successfully launch Organon, including establishment & oversight of Governance & Compliance, Policies & Procedures in line with risk appetite & industry standards;• Responsible for strategic planning, marketing & sales implementation, and overall business unit P&L across ANZ;• Setting local business strategy and key priorities focused on delivering the aspiration of a “better and healthier every day for every woman”; • Building and delivery of short- and long-term financial goals; • Turned around the Company's priority Brand (Contraception Implant) after 7 years of market share decline;• Launched an innovative device used in childbirth (post-partum haemorrhage) in New Zealand - garnered global support for NZ to be an early launch market given the favourable regulatory environment;• Led Women’s Health Sales and Marketing team representing over 30% of the total ANZ headcount with a very high engagement score of 95% achieved across 2 years of annual surveys. Show less

MSD Australia - a ~45B USD company with ~70,000 employees.Board Engagements:• Working with Board oversight, compliance and, risk mitigation and, strategic planning, financials. • Presented to Board strategic marketing plans, long-range and financial plans;• Member of Country Leadership Team; Country Compliance Committee member; Risk Mitigation and Cyber security/incident Management Committee.Executive engagements:• As Business Unit Director, I led multiple… Show more MSD Australia - a ~45B USD company with ~70,000 employees.Board Engagements:• Working with Board oversight, compliance and, risk mitigation and, strategic planning, financials. • Presented to Board strategic marketing plans, long-range and financial plans;• Member of Country Leadership Team; Country Compliance Committee member; Risk Mitigation and Cyber security/incident Management Committee.Executive engagements:• As Business Unit Director, I led multiple business units with team sizes ranging from 30-60 people and P&L responsibilities ranging from $120 to $350Mill PA; • Led a range of diverse portfolios, which included Specialty Care (Fertility, Virology & Hospital), Biosimilars and Key Account Management (tendering, commercial trade).• Created a market-leading biosimilars team and three biosimilar launches across hospital and retail. • Established MSD as No.1 Biosimilar company underpinned by innovation;• Established MSD as the No.1 Hospital Acute Care company in Australia, underpinned by key account management with a strong customer & digital focus;• Teams MSD Company Voice Survey results demonstrated 10/15 categories improved. 9/15 categories above the high-performance norm;• Managed Partner company Alliances in Vaccines & Established Brands. Show less

• Built an understanding of key enterprise support functions & responsibilities, including MSD Australia Operational Compliance, Digital customer engagement & Customer service, SFE & CRM systems, Administrative support, Supply Chain management, Learning & Development.

• Premarketing and launch planning for MSDs flagship Oncology medicine, Keytruda, for melanoma and lung cancer indications;• Led cross-functional team & key scientific leaders engagement plan, built Portfolio vision and innovative access plan to achieve North Star goal, “get Keytruda to patients as quickly as possible”.